
Liverpool ChiroChem (LCC) specialises in providing chiral small molecules to support biotech and pharmaceutical research and development. Its proprietary PACE⢠platform enables faster drug discovery by offering access to a diverse and novel chiral chemical space. LCC supplies essential building blocks, fragments and intermediates for drug discovery, with the capability to produce compounds at scales ranging from milligrams to multi-kilograms.
- Investment status Current
- Invested 2015
- Category Health & Life Sciences